Trial Profile

A Cohort Study of Patients With Metastatic Colorectal Cancer Treated With Avastin® as First-line Therapy for Liver Metastases Considered as Potentially Resectable

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 29 Apr 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bevacizumab (Primary)
Indications Cancer metastases; Colorectal cancer; Liver metastases
Focus Therapeutic Use
Acronyms PICASSO
Sponsors Roche

Most Recent Events

11 Oct 2016 Results (n=153) of KRAS mutational analysis of PICASSO study presented at the 41st European Society for Medical Oncology Congress.
31 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
19 Aug 2014 Planned End Date changed from 1 Sep 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com